Switzerland Approves Pfizer Shot as First Covid-19 Vaccine
- Drug regulator grants authorization for Pfizer/BioNTech shot
- Vaccinations can start in December, health authority says
This article is for subscribers only.
Switzerland has authorized Pfizer Inc.’s and BioNTech SE’s Covid-19 vaccine, the first approved for use in the country.
“The data available to date showed a comparable high level of efficacy in all investigated age groups, thus meeting the safety requirements,” drug regulator Swissmedic said in a statement Saturday, adding that the vaccine can’t yet be given to anyone under 16. “The level of protection afforded seven days after the second injection is over 90% in adults.”